Skanes Allan C, Obeyesekere Manoj, Klein George J
Arrhythmia Services, University Hospital, Western University, 339 Windermere Road, London, Ontario N6A 5A5, Canada.
Department of Cardiology, The Northern Hospital, 185 Copper Street, Epping, Victoria 3076, Australia.
Card Electrophysiol Clin. 2015 Sep;7(3):377-83. doi: 10.1016/j.ccep.2015.05.002. Epub 2015 Jul 7.
The association between asymptomatic Wolff-Parkinson-White (WPW) syndrome and sudden cardiac death (SCD) has been well documented. The inherent properties of the accessory pathway determine the risk of SCD in WPW, and catheter ablation essentially eliminates this risk. An approach to WPW syndrome is needed that incorporates the patient's individualized considerations into the decision making. Patients must understand that there is a trade-off of a small immediate risk of an invasive approach for elimination of a small lifetime risk of the natural history of asymptomatic WPW. Clinicians can minimize the invasive risk by only performing ablation for patients with at-risk pathways.
无症状性预激综合征(WPW)与心源性猝死(SCD)之间的关联已有充分记载。旁路的固有特性决定了WPW患者发生SCD的风险,而导管消融基本上可消除这种风险。需要一种针对WPW综合征的方法,将患者的个体化因素纳入决策过程。患者必须明白,为消除无症状性WPW自然病程中较小的终生风险而采取侵入性方法会带来较小的即时风险,这是一种权衡。临床医生可通过仅对具有高危旁路的患者进行消融来将侵入性风险降至最低。